Patents by Inventor Kevin H. Hazen

Kevin H. Hazen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7620674
    Abstract: The invention comprises transformation of a section of a data block independently of the transformation of separate or overlapping data blocks to determine a property related to the original matrix, where each of the separate or overlapping data blocks are derived from an original data matrix. The transformation enhances parameters of a first data block over a given region of an axis of the data matrix, such as signal-to-noise, without affecting analysis of a second data block derived from the data matrix. This allows for enhancement of analysis of an analyte property, such as concentration, represented within the original data matrix. A separate decomposition and factor selection for each selected data matrix is performed with subsequent score matrix concatenization. The combined score matrix is used to generate a model that is subsequently used to estimate a property, such as concentration represented in the original data matrix.
    Type: Grant
    Filed: October 29, 2004
    Date of Patent: November 17, 2009
    Assignee: Sensys Medical, Inc.
    Inventors: Timothy L. Ruchti, Alexander D. Lorenz, Kevin H. Hazen
  • Patent number: 7606608
    Abstract: An optical sampling interface system is disclosed that minimizes and compensates for errors that result from sampling variations and measurement site state fluctuations. Embodiments of the invention use a guide that does at least one of, induce the formation of a tissue meniscus, minimize interference due to surface irregularities, control variation in the volume of tissue sampled, use a two-part guide system, use a guide that controls rotation of a sample probe and allows z-axis movement of the probe, use a separate base module and sample module in conjunction with a guide, and use a guide that controls rotation. Optional components include an occlusive element and a coupling fluid.
    Type: Grant
    Filed: December 8, 2004
    Date of Patent: October 20, 2009
    Assignee: Sensys Medical, Inc.
    Inventors: Thomas B. Blank, George Acosta, Mutua Mattu, Marcy Makarewicz, Stephen L. Monfre, Alexander D. Lorenz, Timothy L. Ruchti, Kevin H. Hazen, Donovan D. Berry, Roxanne E. Abul-Haj
  • Patent number: 7593230
    Abstract: The invention relates to a heatsink. More particularly, the invention relates to a heatsink having tapered geometry that improves passive cooling efficiency. A tapered geometry between heatsink heat dissipation elements, as a function of distance along a z-axis opposing gravity, decreases resistance to rarification of passively flowing cooling gas upon heating. Thus, the tapered heatsink elements result in higher velocity of gas flow and increased cooling efficiency of the heatsink. Optionally, the heatsink is made from a thermally conductive polymer allowing the heatsink to be created in complex shapes using injection molding.
    Type: Grant
    Filed: July 14, 2005
    Date of Patent: September 22, 2009
    Assignee: Sensys Medical, Inc.
    Inventors: Roxanne E. Abul-Haj, N. Alan Abul-Haj, Timothy W. Stippick, Kevin H. Hazen
  • Publication number: 20090098587
    Abstract: A method of screening for disorders of glucose metabolism such as impaired glucose tolerance and diabetes allows prevention, or early detection and treatment of diabetic complications such as cardiovascular disease, retinopathy, and other disorders of the major organs and systems. A mathematical algorithm evaluates the shape of a subject's glucose profile and classifies the profile into one of several predefined clusters, each cluster corresponding either to a normal condition or one of several abnormal conditions. The series of blood glucose values making up the glucose tolerance curve may be measured using any glucose analyzer including: invasive, minimally invasive and noninvasive types. The method is executed on a processing device programmed to perform the steps of the method. Depending on the outcome of the screening, a subject may be provided with additional information concerning their condition and/or counseled to consult further with their health care provider.
    Type: Application
    Filed: April 8, 2008
    Publication date: April 16, 2009
    Applicant: SENSYS MEDICAL, INC.
    Inventors: Donald Hetzel, Stephen L. Monfre, Kevin H. Hazen, Timothy L. Ruchti, Thomas B. Blank, Linda Hockersmith, Andrew Cone
  • Patent number: 7519406
    Abstract: A method and apparatus are provided for noninvasive sampling. More particularly, the method and apparatus relate to control of motion of an optical sample probe interface relative to a tissue sample site. A dynamic probe interface, is used to collect spectra of a targeted sample, control positioning of the sample probe relative to the tissue sample in terms of at least one of x-, y-, and z-axes, and/or control of sample tissue displacement to minimize spectral variations resulting from the sampling process and increase analyte property estimation precision and accuracy.
    Type: Grant
    Filed: April 27, 2005
    Date of Patent: April 14, 2009
    Assignee: Sensys Medical, Inc.
    Inventors: Thomas B. Blank, George M. Acosta, Timothy L. Ruchti, Mutua Mattu, Alexander D. Lorenz, Kevin H. Hazen, James R. Henderson
  • Patent number: 7505801
    Abstract: A placement guide apparatus with an improved hydration inducing plug used in coupling a noninvasive analyzer to a sampling site to determine analyte in the human body is disclosed. The hydration inducing plug includes at least one fluoropolymer that may be used as a coupling agent. The guide apparatus may further include an automated or semi-automated coupling fluid delivery system. Use of either of these couplers mitigates issues associated with related technology and enhances noninvasive analyte measurements, such as a near-IR diffuse reflectance based noninvasive glucose concentration analyzer.
    Type: Grant
    Filed: August 30, 2007
    Date of Patent: March 17, 2009
    Assignee: Sensys Medical, Inc.
    Inventors: Stephen L. Monfre, George M. Acosta, Thomas B. Blank, Kevin H. Hazen
  • Publication number: 20090036759
    Abstract: The invention relates generally to a noninvasive spectroscopic based analyzer. More particularly, a collapsible spectrometer and or deployable subject interface for an analyzer, such as a noninvasive glucose concentration analyzer, is described.
    Type: Application
    Filed: July 24, 2008
    Publication date: February 5, 2009
    Inventors: Timothy E. Ault, Stephen L. Monfre, Kevin H. Hazen
  • Publication number: 20080316478
    Abstract: Methods and apparatus for enhancing reference spectra are presented. Movement of a reference material relative to a spectrometer optical path is used to enhance reference spectra precision. Alternatively, changing an optically sampled area and/or volume of a reference material during collection of a reference spectrum is used to enhance reference spectra precision. Two separate cases are treated, where the observed variation removed is dependent upon hardware configuration of an analyzer and position of the analyzer relative to the reference. The first case is reduction or removal of radiance variation. The second case is reduction or removal of spectral variation due to observed diffraction. Enhanced reference spectra precision results in enhanced precision and/or accuracy of associated analyte property determinations.
    Type: Application
    Filed: May 21, 2008
    Publication date: December 25, 2008
    Inventors: Christopher SLAWINSKI, James M. WELCH, N. Alan ABUL-HAJ, Kevin H. HAZEN
  • Publication number: 20080319382
    Abstract: Sampling is controlled in order to enhance analyte concentration estimation derived from noninvasive sampling. More particularly, sampling is controlled using controlled fluid delivery to a region between a tip of a sample probe and a tissue measurement site. The controlled fluid delivery enhances coverage of a skin sample site with the thin layer of fluid. Delivery of contact fluid is controlled in terms of spatial delivery, volume, thickness, distribution, temperature, and/or pressure.
    Type: Application
    Filed: April 24, 2008
    Publication date: December 25, 2008
    Inventors: Thomas B. Blank, Stephen L. Monfre, Kevin H. Hazen, Timothy L. Ruchti, Christopher Slawinski, Sedar R. Brown
  • Patent number: 7440786
    Abstract: The invention relates generally to the extraction and/or presentation of glucose concentrations estimated as a function of time into a format that facilitates conveyance of the underlying information. More particularly, glucose concentration histories are presented in terms of risk of behavior, in a video format, and/or in an audio format. The reduction of data into video format, selected by time period, cluster, or glucose concentration response, into an animated or video presentation allows diagnosis and treatment information to be more readily determined and used. Alternatively, glucose concentrations are output through a voice synthesizer or an earcon. These information presentations are useful for both the medical professional and the end user. The information presentation is preferably used with a noninvasive, implantable, semi-continuous, and/or continuous analyte analyzer, such as a glucose concentration analyzer.
    Type: Grant
    Filed: December 14, 2004
    Date of Patent: October 21, 2008
    Assignee: Sensys Medical, Inc.
    Inventors: Linda J. Hockersmith, Kevin H. Hazen, Timothy L. Ruchti
  • Patent number: 7436511
    Abstract: The invention comprises a method and apparatus for enhancing the analysis of noninvasive spectra, resulting in improved analytical performance. More particularly, the invention comprises a method and apparatus for processing noninvasive spectra with an analyte filter that preferably rejects variation likely to be detrimental to the measurement system, while passing signal that probabilistically is unique to the target analyte. Subsequently, the analyte filtered data are used to estimate an analyte property, such as a glucose concentration, in the presence of noise, interferences, state changes, and/or across analyzers.
    Type: Grant
    Filed: July 22, 2005
    Date of Patent: October 14, 2008
    Assignee: Sensys Medical, Inc.
    Inventors: Timothy L. Ruchti, Alexander D. Lorenz, Kevin H. Hazen
  • Patent number: 7395158
    Abstract: A method of screening for disorders of glucose metabolism such as impaired glucose tolerance and diabetes allows prevention, or early detection and treatment of diabetic complications such as cardiovascular disease, retinopathy, and other disorders of the major organs and systems. A mathematical algorithm evaluates the shape of a subject's glucose profile and classifies the profile into one of several predefined clusters, each cluster corresponding either to a normal condition or one of several abnormal conditions. The series of blood glucose values making up the glucose tolerance curve may be measured using any glucose analyzer including: invasive, minimally invasive and noninvasive types. The method is executed on a processing device programmed to perform the steps of the method. Depending on the outcome of the screening, a subject may be provided with additional information concerning their condition and/or counseled to consult further with their health care provider.
    Type: Grant
    Filed: August 13, 2002
    Date of Patent: July 1, 2008
    Assignee: Sensys Medical, Inc.
    Inventors: Stephen L. Monfre, Linda Hockersmith, Donald Hetzel, Kevin H. Hazen, Andrew Cone
  • Publication number: 20080146899
    Abstract: A method and apparatus for easing the use of an optically based noninvasive analyzer is presented. More particularly, a simplified algorithm is used that removes the daily requirement of collecting and using a noninvasive spectrum to update a calibration model. In another embodiment, a guide is used to substantially reduce variation in sample probe placement in relation to a skin tissue sampling site, resulting in the ability to maintain calibration performance with the use of a reference analyte concentration, with or without the use of a reference spectrum collected nearby in time.
    Type: Application
    Filed: February 7, 2008
    Publication date: June 19, 2008
    Inventors: Timothy L. RUCHTI, Kevin H. Hazen, Thomas B. Blank
  • Patent number: 7383069
    Abstract: A method and apparatus for easing the use of an optically based noninvasive analyzer is presented. More particularly, a simplified algorithm is used that removes the daily requirement of collecting and using a noninvasive spectrum to update a calibration model. In another embodiment, a guide is used to substantially reduce variation in sample probe placement in relation to a skin tissue sampling site, resulting in the ability to maintain calibration performance with the use of a reference analyte concentration, with or without the use of a reference spectrum collected nearby in time.
    Type: Grant
    Filed: May 18, 2004
    Date of Patent: June 3, 2008
    Assignee: Sensys Medical, Inc.
    Inventors: Timothy L. Ruchti, Kevin H. Hazen, Thomas B. Blank
  • Patent number: 7333843
    Abstract: A placement guide apparatus with an improved hydration inducing plug used in coupling a noninvasive analyzer to a sampling site to determine analyte in the human body is disclosed. The hydration inducing plug includes at least one fluoropolymer that may be used as a coupling agent. The guide apparatus may further include an automated or semi-automated coupling fluid delivery system. Use of either of these couplers mitigates issues associated with related technology and enhances noninvasive analyte measurements, such as a near-IR diffuse reflectance based noninvasive glucose concentration analyzer.
    Type: Grant
    Filed: April 13, 2004
    Date of Patent: February 19, 2008
    Assignee: Sensys Medical, Inc.
    Inventors: Stephen L. Monfre, George Acosta, Thomas B. Blank, Kevin H. Hazen
  • Patent number: 7299080
    Abstract: A near IR spectrometer-based analyzer attaches continuously or semi-continuously to a human subject and collects spectral measurements for determining a biological parameter in the sampled tissue, such as glucose concentration. The analyzer includes an optical system optimized to target the cutaneous layer of the sampled tissue so that interference from the adipose layer is minimized. The optical system includes at least one optical probe. Spacing between optical paths and detection fibers of each probe and between probes is optimized to minimize sampling of the adipose subcutaneous layer and to maximize collection of light backscattered from the cutaneous layer. Penetration depth is optimized by limiting range of distances between paths and detection fibers. Minimizing sampling of the adipose layer greatly reduces interference contributed by the fat band in the sample spectrum, increasing signal-to-noise ratio.
    Type: Grant
    Filed: April 7, 2004
    Date of Patent: November 20, 2007
    Assignee: Sensys Medical, Inc.
    Inventors: George Acosta, James R. Henderson, N. Alan Abul-Haj, Timothy L. Ruchti, Stephen L. Monfre, Thomas B. Blank, Kevin H. Hazen
  • Patent number: 7183102
    Abstract: A method and apparatus for calibrating noninvasive or implantable glucose analyzers that uses either alternative invasive glucose determinations or noninvasive glucose determinations to calibrate noninvasive or implantable glucose analyzers. Use of an alternative invasive or noninvasive glucose determination in the calibration allows minimization of errors due to sampling methodology, and spatial and temporal variations that are built into the calibration model. An additional embodiment uses statistical correlations between noninvasive and alternative invasive glucose determinations and traditional invasive glucose determinations to adjust noninvasive or alternative invasive glucose concentrations to traditional invasive glucose concentrations. The invention provides a means for calibrating on the basis of glucose determinations that reflect the matrix observed and the variable measured by the analyzer more closely.
    Type: Grant
    Filed: May 4, 2005
    Date of Patent: February 27, 2007
    Assignee: Sensys Medical, Inc.
    Inventors: Stephen L. Monfre, Kevin H. Hazen, Timothy L. Ruchti, Thomas B. Blank, James R. Henderson
  • Patent number: 7133710
    Abstract: The invention involves the monitoring of a biological parameter through a compact analyzer. The preferred apparatus is a spectrometer based system that is attached continuously or semi-continuously to a human subject and collects spectral measurements that are used to determine a biological parameter in the sampled tissue. The preferred target analyze is glucose. The preferred analyzer is a near-IR based glucose analyzer for determining the glucose concentration in the body.
    Type: Grant
    Filed: March 7, 2003
    Date of Patent: November 7, 2006
    Assignee: Sensys Medical, Inc.
    Inventors: George M. Acosta, James R. Henderson, N. Alan Abul Haj, Timothy L. Ruchti, Stephen L. Monfre, Thomas B. Blank, Kevin H. Hazen
  • Patent number: 7038774
    Abstract: Spectrometer instruments are characterized by classifying their spectra into previously defined clusters. The spectra are mapped to the clusters and a classification is made based on similarity of extracted spectral features to one of the previously defined clusters. Calibration models for each cluster are provided to compensate for instrumental variation. Calibration models are provided either by transferring a master calibration to slave calibrations or by calculating a separate calibration for each cluster. In one embodiment, a simplified method of calibration transfer maps clusters to each other, so that a calibration transferred between clusters models only the difference between the two clusters, substantially reducing the complexity of the model.
    Type: Grant
    Filed: June 16, 2004
    Date of Patent: May 2, 2006
    Assignee: Sensys Medical, Inc.
    Inventors: Kevin H. Hazen, Thomas B. Blank, Stephen Monfre, Timothy L. Ruchti
  • Patent number: 7039446
    Abstract: Methods and system for noninvasive determination of tissue analytes utilize tissue properties as reflected in key features of an analytical signal to improve measurement accuracy and precision. Physiological conditions such as changes in water distribution among tissue compartments lead to complex alterations in the measured analytical signal of skin, leading to a biased noninvasive analyte measurement. Changes in the tissue properties are detected by identifying key features in the analytical signal responsive to physiological variations. Conditions not conducive to the noninvasive measurement are detected. Noninvasive measurements that are biased by physiological changes in tissue are compensated. In an alternate embodiment, the analyte is measured indirectly based on natural physiological response of tissue to changes in analyte concentration. A system capable of such measurements is provided.
    Type: Grant
    Filed: January 22, 2003
    Date of Patent: May 2, 2006
    Assignee: Sensys Medical, Inc.
    Inventors: Timothy L. Ruchti, Thomas B. Blank, Alexander D. Lorenz, Stephen L. Monfre, Kevin H. Hazen, Suresh N. Thennadil